Determining the Prevalence of and the Factors Associated with Antihypertensive Medication Non-Adherence in the Gaza Strip
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: This study aimed to estimate the prevalence of and determine the factors associated with antihypertensive medication (A-HTNM) non-adherence among hypertension care seekers attending primary health clinics in the Gaza Strip. Methods: A cross-sectional survey was conducted as the recruitment phase of a clustered randomized controlled trial including 538 participants. The participants were randomly selected from 10 primary health care centers by two-stage cluster random sampling. A structured questionnaire was used to collect data through face-to-face interview. The questionnaire was developed based on the World Health Organization determinants for medication non-adherence and the Health Belief Model. The main outcomes of this study were the prevalences of A-HTNM non-adherence and its associated factors. Adherence status was assessed using the eight-item Morisky Self-Report Medication Adherence Scale. Data were analyzed by STATA ver. 14.0 (Stata Corp., College Station, TX, USA) using a standard complex survey, accounting for unresponsiveness and the clustering sampling approach. Results: The overall prevalence of A-HTNM non-adherence was 65.8% (95% confidence interval [CI], 59.2–71.8). Among all studied predictors, only self-efficacy of participants (odds ratio [OR], 3.8; 95% CI, 1.79–2.84) and social support (OR, 2.26; 95% CI, 2.82–5.11) remained significantly associated with A-HTNM non-adherence after adjusting for age, education level, number and frequency of A-HTNM doses per day, and comorbidities. Conclusion: The high prevalence of non-adherence highlights the need for serious intervention to enhance the adherence rate among hypertension patients. The associated factors can be considered when developing appropriate interventions.
Abstract
Background: This study aimed to estimate the prevalence of and determine the factors associated with antihypertensive medication (A-HTNM) non-adherence among hypertension care seekers attending primary health clinics in the Gaza Strip. Methods: A cross-sectional survey was conducted as the recruitment phase of a clustered randomized controlled trial including 538 participants. The participants were randomly selected from 10 primary health care centers by two-stage cluster random sampling. A structured questionnaire was used to collect data through face-to-face interview. The questionnaire was developed based on the World Health Organization determinants for medication non-adherence and the Health Belief Model. The main outcomes of this study were the prevalences of A-HTNM non-adherence and its associated factors. Adherence status was assessed using the eight-item Morisky Self-Report Medication Adherence Scale. Data were analyzed by STATA ver. 14.0 (Stata Corp., College Station, TX, USA) using a standard complex survey, accounting for unresponsiveness and the clustering sampling approach. Results: The overall prevalence of A-HTNM non-adherence was 65.8% (95% confidence interval [CI], 59.2–71.8). Among all studied predictors, only self-efficacy of participants (odds ratio [OR], 3.8; 95% CI, 1.79–2.84) and social support (OR, 2.26; 95% CI, 2.82–5.11) remained significantly associated with A-HTNM non-adherence after adjusting for age, education level, number and frequency of A-HTNM doses per day, and comorbidities. Conclusion: The high prevalence of non-adherence highlights the need for serious intervention to enhance the adherence rate among hypertension patients. The associated factors can be considered when developing appropriate interventions.
참고문헌 (30)
- Mosleh M, "Burden of chronic disease in the Palestinian healthcare sector using Disability-Adjusted Life Years (DALY), Palestine", Divers Equal Health Care, 13, pp.261~268 (2016)
- hdour MR, "Prevalence, awareness, treatment and control of hypertension in the Palestinian population", J Hum Hypertens, 27, pp.623~628 (2013)
- James PA, "2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)", JAMA, 311, pp.507~520 (2014)
- Whelton PK, "2017 ACC", AHA, ABC, pp.ACPM, AGS[DOI]
- Gosmanova EO, "Adherence to antihypertensive medications: is prescribing the right pill enough?", Nephrol Dial Transplant, 30, pp.1649~1656 (2015)
- Blackwell B, "Drug therapy: patient compliance", N Engl J Med, 1973(289), pp.249~252 (1973)
- Sabate E, "Adherence to long-term therapies: evidence for action" (2003), World Health Organization
- Elliott WJ, "Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy", J Clin Hypertens (Greenwich), 11, pp.376~382 (2009)
- Abegaz TM, "Nonadherence to antihypertensive drugs: a systematic review and meta-analysis", Medicine (Baltimore), 96, pp.e5641~ (2017)
- World Health organization, "World Health Day 2013", World Health Organization, ~ (2013)
- Kamran A, "Determinants of patient’s adherence to hypertension medications: application of health belief model among rural patients", Ann Med Health Sci Res, 4, pp.922~927 (2014)
- Morisky DE, "Predictive validity of a medication adherence measure in an outpatient setting", J Clin Hypertens (Greenwich), 10, pp.348~354 (2008)
- Alsolami F, "Factors affecting antihypertensive medications adherence among hypertensive patients in Saudi Arabia", Am J Med Med Sci, 5, pp.181~189 (2015)
- Sjolander M, "The association between patients’ beliefs about medicines and adherence to drug treatment after stroke: a cross-sectional questionnaire survey", BMJ Open, 3, pp.e003551~ (2013)
- Warren-Findlow J, "The association between self-efficacy and hypertension self-care activities among African American adults", J Community Health, 37, pp.15~24 (2012)
- Pelletier LG, "Client motivation for therapy scale: a measure of intrinsic motivation, extrinsic motivation, and amotivation for therapy", J Pers Assess, 68, pp.414~435 (1997)
- Van der Feltz-Cornelis CM, "A patient-doctor relationship questionnaire (PDRQ-9) in primary care: development and psychometric evaluation", Gen Hosp Psychiatry, 26, pp.115~120 (2004)
- Ogedegbe C, "Health care workers and disaster preparedness: barriers to and facilitators of willingness to respond", Int J Emerg Med, 5, pp.29~ (2012)
- World Health Organization, "Process of translation and adaptation of instruments" (2018), World Health Organization
- Charlson ME, "A new method of classifying prognostic comorbidity in longitudinal studies: development and validation", J Chronic Dis, 40, pp.373~383 (1987)
- Koo TK, "A guideline of selecting and reporting intraclass correlation coefficients for reliability research", J Chiropr Med, 15, pp.155~163 (2016)
- Abed Y, "Risk factors of hypertension at UNRWA primary health care centers in Gaza governorates", ISRN Epidemiol, 2013, pp.720760~ (2013)
- 최효윤, "Factors Affecting Adherence to Antihypertensive Medication", Korean Journal of Family Medicine, 39(6), pp.325~332 (2018), 대한가정의학회
- Hashmi SK, "Factors associated with adherence to anti-hypertensive treatment in Pakistan", PLoS One, 2, pp.e280~ (2007)
- Osterberg L, "Adherence to medication", N Engl J Med, 353, pp.487~497 (2005)
- Lam WY, "Medication adherence measures: an overview", Biomed Res Int, 2015, pp.217047~ (2015)
- Al-Ramahi R, "Adherence to medications and associated factors: a cross-sectional study among Palestinian hypertensive patients", J Epidemiol Glob Health, 5, pp.125~132 (2015)
- An J, "Multiple medication adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension", Med Care, 51, pp.879~887 (2013)
- Criswell TJ, "Effect of self-efficacy and social support on adherence to antihypertensive drugs", Pharmacotherapy, 30, pp.432~441 (2010)
- Magrin ME, "Social support and adherence to treatment in hypertensive patients: a meta-analysis", Ann Behav Med, 49, pp.307~318 (2015)